Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
| Last: | $15.655 |
|---|---|
| Change Percent: | 1.92% |
| Open: | $15.68 |
| Close: | $15.36 |
| High: | $15.74 |
| Low: | $15.03 |
| Volume: | 1,146,778 |
| Last Trade Date Time: | 03/09/2026 12:45:59 pm |
| Market Cap: | $3,926,963,123 |
|---|---|
| Float: | 229,191,848 |
| Insiders Ownership: | 0.3% |
| Institutions: | 148 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.admabiologics.com |
| Country: | US |
| City: | Ramsey |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about ADMA Biologics Inc (NASDAQ: ADMA).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
